| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |